CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (4734) Cancer Therapeutics (1145)
ImmunoMet Therapeutics is a development-stage biotechnology company focused on utilizing cellular metabolism to develop anti-tumor and immuno-oncology therapies.
Company (Alive / Active)
Phone: 346-772-0318
2450 Holcombe Blvd
Houston, 77021
Texas, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| ImmunoMet Therapeutics | $10.2M | Mar 7, 2017 |
| Neon Therapeutics | $261M | Jun 27, 2018 |
| BeneVir Biopharm | $10M | May 2, 2018 |
| See all 12 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| N1-cyclic amine-n5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same | Feb 06, 2014 | Feb 06, 2018 | Patent |
| Pharmaceutical composition comprising a biguanide derivative as an active ingredient for preventing or treating glioblastoma | May 13, 2016 | Jan 10, 2017 | Patent |
| N1-cyclic amine-n5-substituted phenyl biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same | Aug 08, 2012 | Jan 10, 2017 | Patent |
| Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient | Sep 08, 2015 | Oct 11, 2016 | Patent |
| Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient | Jan 06, 2011 | Aug 16, 2016 | Patent |
